OrthoPediatrics Corp (KIDS)
25.93
+0.29
(+1.13%)
USD |
NASDAQ |
Oct 04, 16:00
25.91
-0.02
(-0.08%)
After-Hours: 20:00
OrthoPediatrics Research and Development Expense (Annual): 10.20M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.20M |
| December 31, 2022 | 8.014M |
| December 31, 2021 | 5.543M |
| December 31, 2020 | 5.273M |
| December 31, 2019 | 5.748M |
| Date | Value |
|---|---|
| December 31, 2018 | 4.732M |
| December 31, 2017 | 3.423M |
| December 31, 2016 | 2.223M |
| December 31, 2015 | 1.789M |
| December 31, 2014 | 1.683M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
5.273M
Minimum
2020
10.20M
Maximum
2023
6.955M
Average
5.748M
Median
2019
Research and Development Expense (Annual) Benchmarks
| The Cooper Companies Inc | 137.40M |
| Staar Surgical Co | 44.40M |
| NexGel Inc | 0.103M |
| Innovative Eyewear Inc | 0.6622M |
| Perspective Therapeutics Inc | 21.31M |